Impact of preoperative use of P2Y12 receptor inhibitors on clinical outcomes in cardiac and non-cardiac surgery: A systematic review and meta-analysis

European Heart Journal: Acute Cardiovascular Care

Volumn 6, Issue 8, 2017, Pages 753-770

  Siller Matula, Jolanta M ^a   Petre, Alexandra ^a   Delle Karth, Georg ^a   Huber, Kurt ^b   Ay, Cihan ^a   Lordkipanidzé, Marie ^c   De Caterina, Raffaele ^d   Kolh, Philippe ^e   Mahla, Elisabeth ^f   Gersh, Bernard J ^g  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

^b WILHELMINEN HOSPITAL   (Austria)

^c MONTREAL HEART INSTITUTE   (Canada)

^d UNIVERSITY OF CHIETI   (Italy)

^e UNIVERSITY OF LIÈGE   (Belgium)

^f MEDICAL UNIVERSITY OF GRAZ   (Austria)

^g MAYO CLINIC   (United States)

Author keywords

CABG; Clopidogrel; prasugrel; surgery; ticagrelor

Indexed keywords

CLOPIDOGREL; PRASUGREL; PURINERGIC P2Y12 RECEPTOR; PURINERGIC RECEPTOR BLOCKING AGENT; TICAGRELOR; PURINERGIC P2Y RECEPTOR ANTAGONIST;

BLEEDING; CORONARY ARTERY BYPASS GRAFT; DEATH; HEART INFARCTION; HEMATOMA; HUMAN; META ANALYSIS; MORTALITY; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; REOPERATION; REVIEW; SENSITIVITY ANALYSIS; SYSTEMATIC REVIEW; TREATMENT OUTCOME; COMPLICATION; CORONARY ARTERY DISEASE; HEART SURGERY; PREOPERATIVE CARE; PROCEDURES; PROGNOSIS;

CARDIAC SURGICAL PROCEDURES; CORONARY ARTERY DISEASE; HUMANS; PREOPERATIVE CARE; PROGNOSIS; PURINERGIC P2Y RECEPTOR ANTAGONISTS; SURGICAL PROCEDURES, OPERATIVE;

EID: 85044688865     PISSN: 20488726     EISSN: 20488734     Source Type: Journal    
DOI: 10.1177/2048872615585516     Document Type: Review

References (93)

1. Hochtl T, Sinnaeve PR, Adriaenssens T. Oral antiplatelet therapy in acute coronary syndromes: Update 2012. Eur Heart J Acute Cardiovasc Care 2012; 1: 79–86.
2. Badimon L, Padro T, Vilahur G. Atherosclerosis, platelets and thrombosis in acute ischaemic heart disease. Eur Heart J Acute Cardiovasc Care 2012; 1: 60–74.
3. Windecker S, Kolh P, Alfonso F. 2014 ESC/EACTS Guidelines on myocardial revascularization: The Task Force on Myocardial Revascularization of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS)Developed with the special contribution of the European Association of Percutaneous Cardiovascular Interventions (EAPCI). Eur Heart J 2014; 35:2541–2619.
4. Hamm CW, Bassand JP, Agewall S.; ESC Committee for Practice Guidelines. ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: The Task Force for the management of acute coronary syndromes (ACS) in patients presenting without persistent ST-segment elevation of the European Society of Cardiology (ESC). Eur Heart J 2011; 32: 2999–3054.
5. Ebrahimi R, Dyke C, Mehran R. Outcomes following pre-operative clopidogrel administration in patients with acute coronary syndromes undergoing coronary artery bypass surgery: The ACUITY (Acute Catheterization and Urgent Intervention Triage strategY) trial. J Am Coll Cardiol 2009; 53: 1965–1972.
6. Held C, Asenblad N, Bassand JP. Ticagrelor versus clopidogrel in patients with acute coronary syndromes undergoing coronary artery bypass surgery: Results from the PLATO (Platelet Inhibition and Patient Outcomes) trial. J Am Coll Cardiol 2011; 57: 672–684.
7. Smith PK, Goodnough LT, Levy JH. Mortality benefit with prasugrel in the TRITON-TIMI 38 coronary artery bypass grafting cohort: Risk-adjusted retrospective data analysis. J Am Coll Cardiol 2012; 60: 388–396.
8. Hawn MT, Graham LA, Richman JS. Risk of major adverse cardiac events following noncardiac surgery in patients with coronary stents. JAMA 2013; 310: 1462–1472.
9. Berger JS, Frye CB, Harshaw Q. Impact of clopidogrel in patients with acute coronary syndromes requiring coronary artery bypass surgery: A multicenter analysis. J Am Coll Cardiol 2008; 52: 1693–1701.
10. Herman CR, Buth KJ, Kent BA. Clopidogrel increases blood transfusion and hemorrhagic complications in patients undergoing cardiac surgery. Ann Thorac Surg 2010; 89: 397–402.
11. Kaluza GL, Joseph J, Lee JR. Catastrophic outcomes of noncardiac surgery soon after coronary stenting. J Am Coll Cardiol 2000; 35: 1288–1294.
12. Vicenzi MN, Meislitzer T, Heitzinger B. Coronary artery stenting and non-cardiac surgery – a prospective outcome study. Br J Anaesth 2006; 96: 686–693.
13. Ouattara A, Bouzguenda H, Le Manach Y. Impact of aspirin with or without clopidogrel on postoperative bleeding and blood transfusion in coronary surgical patients treated prophylactically with a low-dose of aprotinin. Eur Heart J 2007; 28: 1025–1032.
14. Shi J, Ji H, Ren F. Protective effects of tranexamic acid on clopidogrel before coronary artery bypass grafting: A multicenter randomized trial. JAMA Surg 2013; 148: 538–547.
15. Eisenberg MJ, Richard PR, Libersan D. Safety of short-term discontinuation of antiplatelet therapy in patients with drug-eluting stents. Circulation 2009; 119: 1634–1642.
16. Biondi-Zoccai GG, Lotrionte M, Abbate A. Compliance with QUOROM and quality of reporting of overlapping meta-analyses on the role of acetylcysteine in the prevention of contrast associated nephropathy: Case study. BMJ 2006; 332: 202–209.
17. Higgins JP, Thompson SG. Quantifying heterogeneity in a meta-analysis. Stat Med 2002; 21: 1539–1558.
18. Spyropoulos AC, Douketis JD. How I treat anticoagulated patients undergoing an elective procedure or surgery. Blood 2012; 120: 2954–2962.
19. Fox KA, Mehta SR, Peters R.; Clopidogrel in Unstable angina to prevent Recurrent ischemic Events Trial. Benefits and risks of the combination of clopidogrel and aspirin in patients undergoing surgical revascularization for non-ST-elevation acute coronary syndrome: The Clopidogrel in Unstable angina to prevent Recurrent ischemic Events (CURE) Trial. Circulation 2004; 110: 1202–1208.
20. Akowuah E, Shrivastava V, Jamnadas B. Comparison of two strategies for the management of antiplatelet therapy during urgent surgery. Ann Thorac Surg 2005; 80: 149–152.
21. McLean DS, Sabatine MS, Guo W. Benefits and risks of clopidogrel pretreatment before coronary artery bypass grafting in patients with ST-elevation myocardial infarction treated with fibrinolytics in CLARITY-TIMI 28. J Thromb Thrombolysis 2007; 24: 85–91.
22. Firanescu CE, Martens EJ, Schonberger JP. Postoperative blood loss in patients undergoing coronary artery bypass surgery after preoperative treatment with clopidogrel. A prospective randomised controlled study. Eur J Cardiothorac Surg 2009; 36: 856–862.
23. Ascione R, Ghosh A, Rogers CA. In-hospital patients exposed to clopidogrel before coronary artery bypass graft surgery: A word of caution. Ann Thorac Surg 2005; 79: 1210–1216.
24. Badreldin A, Kroener A, Kamiya H. Effect of clopidogrel on perioperative blood loss and transfusion in coronary artery bypass graft surgery. Interact Cardiovasc Thorac Surg 2010; 10: 48–52.
25. Chen L, Bracey AW, Radovancevic R. Clopidogrel and bleeding in patients undergoing elective coronary artery bypass grafting. J Thorac Cardiovasc Surg 2004; 128: 425–431.
26. Chu MW, Wilson SR, Novick RJ. Does clopidogrel increase blood loss following coronary artery bypass surgery? Ann Thorac Surg 2004; 78: 1536–1541.
27. Englberger L, Faeh B, Berdat PA. Impact of clopidogrel in coronary artery bypass grafting. Eur J Cardiothorac Surg 2004; 26: 96–101.
28. Hongo RH, Ley J, Dick SE. The effect of clopidogrel in combination with aspirin when given before coronary artery bypass grafting. J Am Coll Cardiol 2002; 40: 231–237.
29. Kang W, Theman TE, Reed JF, 3rd. The effect of preoperative clopidogrel on bleeding after coronary artery bypass surgery. J Surg Educ 2007; 64: 88–92.
30. Kapetanakis EI, Medlam DA, Boyce SW. Clopidogrel administration prior to coronary artery bypass grafting surgery: The cardiologist’s panacea or the surgeon’s headache? Eur Heart J 2005; 26: 576–583.
31. Kapetanakis EI, Medlam DA, Petro KR. Effect of clopidogrel premedication in off-pump cardiac surgery: Are we forfeiting the benefits of reduced hemorrhagic sequelae? Circulation 2006; 113: 1667–1674.
32. Karabulut H, Toraman F, Evrenkaya S. Clopidogrel does not increase bleeding and allogenic blood transfusion in coronary artery surgery. Eur J Cardiothorac Surg 2004; 25: 419–423.
33. Kim HJ, Levin LF. The management of patients on dual antiplatelet therapy undergoing orthopedic surgery. HSS J 2010; 6: 182–189.
34. Leong JY, Baker RA, Shah PJ. Clopidogrel and bleeding after coronary artery bypass graft surgery. Ann Thorac Surg 2005; 80: 928–933.
35. Maltais S, Perrault LP, Do QB. Effect of clopidogrel on bleeding and transfusions after off-pump coronary artery bypass graft surgery: Impact of discontinuation prior to surgery. Eur J Cardiothorac Surg 2008; 34: 127–131.
36. Mariscalco G, Bruno VD, Cottini M. Optimal timing of discontinuation of clopidogrel and risk of blood transfusion after coronary surgery. Propensity score analysis. Circ J 2011; 75: 2805–2812.
37. Mehta RH, Roe MT, Mulgund J. Acute clopidogrel use and outcomes in patients with non-ST-segment elevation acute coronary syndromes undergoing coronary artery bypass surgery. J Am Coll Cardiol 2006; 48: 281–286.
38. Miceli A, Duggan SM, Aresu G. Combined clopidogrel and aspirin treatment up to surgery increases the risk of postoperative myocardial infarction, blood loss and reoperation for bleeding in patients undergoing coronary artery bypass grafting. Eur J Cardiothorac Surg 2013; 43: 722–728.
39. Nesher N, Singh SK, Fawzy HF. Impact of clopidogrel use on mortality and major bleeding in patients undergoing coronary artery bypass surgery. Interact Cardiovasc Thorac Surg 2010; 10: 732–736.
40. Nurozler F, Kutlu T, Kucuk G. Impact of clopidogrel on postoperative blood loss after non-elective coronary bypass surgery. Interact Cardiovasc Thorac Surg 2005; 4: 546–549.
41. Picker SM, Kaleta T, Hekmat K. Antiplatelet therapy preceding coronary artery surgery: Implications for bleeding, transfusion requirements and outcome. Eur J Anaesthesiol 2007; 24: 332–339.
42. Schmidtler F, Gansera B, Spiliopoulos K. [Urgent or emergent coronary revascularization using bilateral internal thoracic artery after previous clopidogrel antiplatelet therapy]. Z Kardiol 2004; 93: 679–685.
43. Shim JK, Choi YS, Oh YJ. Effects of preoperative aspirin and clopidogrel therapy on perioperative blood loss and blood transfusion requirements in patients undergoing off-pump coronary artery bypass graft surgery. J Thorac Cardiovasc Surg 2007; 134: 59–64.
44. Song SW, Youn YN, Yi G. Effects of continuous administration of clopidogrel before off-pump coronary artery bypass grafting in patients with acute coronary syndrome. Circ J 2008; 72: 626–632.
45. Tabary SZ. Does Plavix have any influences on postoperative bleeding and blood transfusion after urgent and emergent coronary artery bypass grafting. J Med Sci 2008; 8: 293–297.
46. Vaccarino GN, Thierer J, Albertal M. Impact of preoperative clopidogrel in off pump coronary artery bypass surgery: A propensity score analysis. J Thorac Cardiovasc Surg 2009; 137: 309–313.
47. von Heymann C, Redlich U, Moritz M. Aspirin and clopidogrel taken until 2 days prior to coronary artery bypass graft surgery is associated with increased postoperative drainage loss. Thorac Cardiovasc Surg 2005; 53: 341–345.
48. Woo YJ, Grand T, Valettas N. Off-pump coronary artery bypass grafting attenuates postoperative bleeding associated with preoperative clopidogrel administration. Heart Surg Forum 2003; 6: 282–285.
49. Yende S, Wunderink RG. Effect of clopidogrel on bleeding after coronary artery bypass surgery. Crit Care Med 2001; 29: 2271–2275.
50. Blasco-Colmenares E, Perl TM, Guallar E. Aspirin plus clopidogrel and risk of infection after coronary artery bypass surgery. Arch Intern Med 2009; 169: 788–796.
51. Gansera B, Schmidtler F, Spiliopoulos K. Urgent or emergent coronary revascularization using bilateral internal thoracic artery after previous clopidogrel antiplatelet therapy. Thorac Cardiovasc Surg 2003; 51: 185–189.
52. Albaladejo P, Marret E, Samama CM. Non-cardiac surgery in patients with coronary stents: The RECO study. Heart 2011; 97: 1566–1572.
53. Ceppa DP, Welsby IJ, Wang TY. Perioperative management of patients on clopidogrel (Plavix) undergoing major lung resection. Ann Thorac Surg 2011; 92: 1971–1976.
54. Cerfolio RJ, Minnich DJ, Bryant AS. General thoracic surgery is safe in patients taking clopidogrel (Plavix). J Thorac Cardiovasc Surg 2010; 140: 970–976.
55. Chernoguz A, Telem DA, Chu E. Cessation of clopidogrel before major abdominal procedures. Arch Surg 2011; 146: 334–339.
56. Chu EW, Telem DA, Chernoguz A. Assessing the risk of clopidogrel-related bleeding complications in patients undergoing inguinal herniorrhaphy. Hernia 2011; 15: 31–35.
57. Eng M, Brock G, Li X. Perioperative anticoagulation and antiplatelet therapy in renal transplant: Is there an increase in bleeding complication? Clin Transplant 2011; 25: 292–296.
58. van Kuijk JP, Flu WJ, Schouten O. Timing of noncardiac surgery after coronary artery stenting with bare metal or drug-eluting stents. Am J Cardiol 2009; 104: 1229–1234.
59. Rabbitts JA, Nuttall GA, Brown MJ. Cardiac risk of noncardiac surgery after percutaneous coronary intervention with drug-eluting stents. Anesthesiology 2008; 109: 596–604.
60. Rosenbaum A, Rizvi AZ, Alden PB. Outcomes related to antiplatelet or anticoagulation use in patients undergoing carotid endarterectomy. Ann Vasc Surg 2011; 25: 25–31.
61. Payne DA, Jones CI, Hayes PD. Beneficial effects of clopidogrel combined with aspirin in reducing cerebral emboli in patients undergoing carotid endarterectomy. Circulation 2004; 109: 1476–1481.
62. Wait SD, Abla AA, Killory BD. Safety of carotid endarterectomy while on clopidogrel (Plavix). Clinical article. J Neurosurg 2010; 113: 908–912.
63. Stone DH, Goodney PP, Schanzer A. Clopidogrel is not associated with major bleeding complications during peripheral arterial surgery. J Vasc Surg 2011; 54: 779–784.
64. Kutinsky IB, Jarandilla R, Jewett M. Risk of hematoma complications after device implant in the clopidogrel era. Circ Arrhythm Electrophysiol 2010; 3: 312–318.
65. Przybylski A, Derejko P, Kwasniewski W. Bleeding complications after pacemaker or cardioverter-defibrillator implantation in patients receiving dual antiplatelet therapy: Results of a prospective, two-centre registry. Neth Heart J 2010; 18: 230–235.
66. Tompkins C, Cheng A, Dalal D. Dual antiplatelet therapy and heparin ‘bridging’ significantly increase the risk of bleeding complications after pacemaker or implantable cardioverter-defibrillator device implantation. J Am Coll Cardiol 2010; 55: 2376–2382.
67. Wiegand UK, LeJeune D, Boguschewski F. Pocket hematoma after pacemaker or implantable cardioverter defibrillator surgery: Influence of patient morbidity, operation strategy, and perioperative antiplatelet/anticoagulation therapy. Chest 2004; 126: 1177–1186.
68. Hajjar LA, Vincent JL, Galas FR. Transfusion requirements after cardiac surgery: The TRACS randomized controlled trial. JAMA 2010; 304: 1559–1567.
69. Kamel H, Johnston SC, Kirkham JC. Association between major perioperative hemorrhage and stroke or Q-wave myocardial infarction. Circulation 2012; 126: 207–212.
70. Koch CG, Li L, Duncan AI. Morbidity and mortality risk associated with red blood cell and blood-component transfusion in isolated coronary artery bypass grafting. Crit Care Med 2006; 34: 1608–1616.
71. Mehta RH, Sheng S, O’Brien SM.; Society of Thoracic Surgeons National Cardiac Surgery Database Investigators. Reoperation for bleeding in patients undergoing coronary artery bypass surgery: Incidence, risk factors, time trends, and outcomes. Circ Cardiovasc Qual Outcomes 2009; 2: 583–590.
72. Biancari F, Airaksinen KE, Lip GY. Benefits and risks of using clopidogrel before coronary artery bypass surgery: Systematic review and meta-analysis of randomized trials and observational studies. J Thorac Cardiovasc Surg 2012; 143: 665–675 e4.
73. Nijjer SS, Watson G, Athanasiou T. Safety of clopidogrel being continued until the time of coronary artery bypass grafting in patients with acute coronary syndrome: A meta-analysis of 34 studies. Eur Heart J 2011; 32: 2970–2988.
74. Morici N, Moja L, Rosato V. Time from adenosine di-phosphate receptor antagonist discontinuation to coronary bypass surgery in patients with acute coronary syndrome: Meta-analysis and meta-regression. Int J Cardiol 2013; 168: 1955–1964.
75. Au AG, Majumdar SR, McAlister FA. Preoperative thienopyridine use and outcomes after surgery: A systematic review. Am J Med 2012; 125: 87–99 e1.
76. Steg PG, James SK, Atar D. ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation: The Task Force on the management of ST-segment elevation acute myocardial infarction of the European Society of Cardiology (ESC). Eur Heart J 2012; 33: 2569–2619.
77. Mehta RH, Chen AY, Pollack CV, Jr. Challenges in predicting the need for coronary artery bypass grafting at presentation in patients with non-ST-segment elevation acute coronary syndromes. Am J Cardiol 2006; 98: 624–627.
78. Montalescot G, Bolognese L, Dudek D.; for the ACCOAST Investigators. Pretreatment with prasugrel in non-ST-segment elevation acute coronary syndromes. N Engl J Med 2013; 369: 999–1010.
79. Juul N, Gislason G, Olesen JB. Risk and benefit of dual antiplatelet treatment among non-revascularized myocardial infarction patients in different age groups. Eur Heart J Acute Cardiovasc Care 2014. Jun 16. doi: 10.1177/2048872614538848.
80. De Servi S, Goedicke J, Schirmer A. Clinical outcomes for prasugrel versus clopidogrel in patients with unstable angina or non-ST-elevation myocardial infarction: An analysis from the TRITON-TIMI 38 trial. Eur Heart J Acute Cardiovasc Care 2014; 3: 363–372.
81. Siller-Matula JM Trenk D, Schror K. How to improve the concept of individualised antiplatelet therapy with P2Y12 receptor inhibitors–is an algorithm the answer? Thromb Haemost 2015; 113:37–52.
82. Siller-Matula JM, Trenk D, Schror K, Response Variability to P2Y12 Receptor Inhibitors: Expectations and Reality. JACC Cardiovasc Interv 2013; 6:1111–1128.
83. Kurz DJ, Radovanovic D, Seifert B. Comparison of prasugrel and clopidogrel-treated patients with acute coronary syndrome undergoing percutaneous coronary intervention: A propensity score-matched analysis of the Acute Myocardial Infarction in Switzerland (AMIS)-Plus Registry. Eur Heart J Acute Cardiovasc Care Epub ahead of print January 22, 2015, DOI: 10.1177/2048872614566946.
84. Gurbel PA, Bliden KP, Butler K. Randomized double-blind assessment of the ONSET and OFFSET of the antiplatelet effects of ticagrelor versus clopidogrel in patients with stable coronary artery disease: The ONSET/OFFSET study. Circulation 2009; 120: 2577–2585.
85. Savonitto S, Caracciolo M, Cattaneo M. Management of patients with recently implanted coronary stents on dual antiplatelet therapy who need to undergo major surgery. J Thromb Haemost 2011; 9: 2133–2142.
86. Capodanno D, Angiolillo DJ. Management of antiplatelet therapy in patients with coronary artery disease requiring cardiac and noncardiac surgery. Circulation 2013; 128: 2785–2798.
87. Rossini R, Musumeci G, Visconti LO. Perioperative management of antiplatelet therapy in patients with coronary stents undergoing cardiac and non-cardiac surgery: A consensus document from Italian cardiological, surgical and anaesthesiological societies. EuroIntervention 2014; 10: 38–46.
88. Korte W, Cattaneo M, Chassot PG. Peri-operative management of antiplatelet therapy in patients with coronary artery disease: Joint position paper by members of the working group on Perioperative Haemostasis of the Society on Thrombosis and Haemostasis Research (GTH), the working group on Perioperative Coagulation of the Austrian Society for Anesthesiology, Resuscitation and Intensive Care (OGARI) and the Working Group Thrombosis of the European Society for Cardiology (ESC). Thromb Haemost 2011; 105: 743–749.
89. Patrono C, Andreotti F, Arnesen H. Antiplatelet agents for the treatment and prevention of atherothrombosis. Eur Heart J 2011; 32: 2922–2932.
90. Angiolillo DJ, Firstenberg MS, Price MJ.; for the BRIDGE Investigators. Bridging antiplatelet therapy with cangrelor in patients undergoing cardiac surgery: A randomized controlled trial. JAMA 2012; 307: 265–274.
91. Sun JC, Whitlock R, Cheng J. The effect of pre-operative aspirin on bleeding, transfusion, myocardial infarction, and mortality in coronary artery bypass surgery: A systematic review of randomized and observational studies. Eur Heart J 2008; 29: 1057–1071.
92. Mahla E, Suarez TA, Bliden KP. Platelet function measurement-based strategy to reduce bleeding and waiting time in clopidogrel-treated patients undergoing coronary artery bypass graft surgery: The timing based on platelet function strategy to reduce clopidogrel-associated bleeding related to CABG (TARGET-CABG) study. Circ Cardiovasc Interv 2012; 5: 261–269.
93. Tantry US, Bonello L, Aradi D.; Working Group on On-Treatment Platelet Reactivity. Consensus and update on the definition of on-treatment platelet reactivity to adenosine diphosphate associated with ischemia and bleeding. J Am Coll Cardiol 2013; 62: 2261–2273.